K
K. Sundby Hall
Researcher at Oslo University Hospital
Publications - 19
Citations - 2482
K. Sundby Hall is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Sarcoma & Bone Sarcoma. The author has an hindex of 12, co-authored 19 publications receiving 1736 citations. Previous affiliations of K. Sundby Hall include University of Oslo.
Papers
More filters
Journal ArticleDOI
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Paolo G. Casali,N. Abecassis,Sebastian Bauer,R. Biagini,Stefan S. Bielack,Sylvie Bonvalot,Ioannis Boukovinas,Judith V.M.G. Bovée,Thomas Brodowicz,Javier Martin Broto,Angela Buonadonna,E. de Álava,A. P. Dei Tos,X.G. del Muro,Palma Dileo,Mikael Eriksson,Alexander Fedenko,Virginia Ferraresi,Andrea Ferrari,Silvia Ferrari,A.M. Frezza,Silvia Gasperoni,Hans Gelderblom,Thierry Gil,Giovanni Grignani,Alessandro Gronchi,Rick L. Haas,A. Hannu,B. Hassan,Peter Hohenberger,Rolf D. Issels,Heikki Joensuu,Robin L. Jones,Ian Judson,Paul C Jutte,Suzanne E. J. Kaal,Bernd Kasper,Katerina Kopeckova,D.A. Krakorova,A. Le Cesne,Iwona Lugowska,Ofer Merimsky,Michael Montemurro,Maria Abbondanza Pantaleo,R. Piana,Piero Picci,S. Piperno-Neumann,Antonio López Pousa,Peter Reichardt,M.H. Robinson,Piotr Rutkowski,Akmal Safwat,Patrick Schöffski,Stefan Sleijfer,Silvia Stacchiotti,K. Sundby Hall,M. Unk,F. van Coevorden,W.T.A. van der Graaf,Jeremy Whelan,Eva Wardelmann,Olga Zaikova,Jean-Yves Blay +62 more
Journal ArticleDOI
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Paolo G. Casali,N. Abecassis,Sebastian Bauer,R. Biagini,Stefan S. Bielack,Sylvie Bonvalot,Ioannis Boukovinas,Judith V.M.G. Bovée,Thomas Brodowicz,Javier Martin Broto,Angela Buonadonna,E. de Álava,A. P. Dei Tos,X.G. del Muro,Palma Dileo,Mikael Eriksson,A. Fedenko,Virginia Ferraresi,Andrea Ferrari,S. Ferrari,A.M. Frezza,Silvia Gasperoni,Hans Gelderblom,Thierry Gil,Giovanni Grignani,Alessandro Gronchi,Rick L. Haas,A. Hannu,B. Hassan,Peter Hohenberger,Rolf D. Issels,Heikki Joensuu,Robin L. Jones,Ian Judson,Paul C Jutte,Suzanne E. J. Kaal,Bernd Kasper,Katerina Kopeckova,D.A. Krakorova,A. Le Cesne,Iwona Lugowska,Ofer Merimsky,Michael Montemurro,Maria Abbondanza Pantaleo,R. Piana,P. Picci,S. Piperno-Neumann,Antonio López Pousa,Peter Reichardt,M.H. Robinson,Piotr Rutkowski,Akmal Safwat,Patrick Schöffski,Stefan Sleijfer,Silvia Stacchiotti,K. Sundby Hall,M. Unk,F. van Coevorden,W.T.A. van der Graaf,Jeremy Whelan,E. Wardelmann,Olga Zaikova,Jean-Yves Blay +62 more
TL;DR: Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon, Portugal; University Hospital Essen, Essen Germany; Department of Oncological Orthopedics, Musculoskeletal Tissue Bank, IFO, Regina Elena National Cancer Institute, Rome, Italy.
Journal ArticleDOI
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali,Stefan S. Bielack,N. Abecassis,Hannu T. Aro,Sebastian Bauer,R. Biagini,Sylvie Bonvalot,Ioannis Boukovinas,Judith V.M.G. Bovée,Bernadette Brennan,Thomas Brodowicz,Javier Martin Broto,Laurence Brugières,Angela Buonadonna,E. de Álava,A. P. Dei Tos,X.G. del Muro,Palma Dileo,Catharina Dhooge,Mikael Eriksson,Franca Fagioli,Alexander Fedenko,Virginia Ferraresi,Andrea Ferrari,S. Ferrari,A.M. Frezza,Nathalie Gaspar,Silvia Gasperoni,Hans Gelderblom,Thierry Gil,Giovanni Grignani,Alessandro Gronchi,Rick L. Haas,B. Hassan,Stefanie Hecker-Nolting,Peter Hohenberger,Rolf D. Issels,Heikki Joensuu,Robin L. Jones,Ian Judson,Paul C Jutte,Suzanne E. J. Kaal,Leo Kager,Bernd Kasper,Katerina Kopeckova,D.A. Krakorova,Ruth Ladenstein,A. Le Cesne,Iwona Lugowska,Ofer Merimsky,Michael Montemurro,Bruce Morland,Maria Abbondanza Pantaleo,R. Piana,P. Picci,S. Piperno-Neumann,Antonio López Pousa,Peter Reichardt,M.H. Robinson,Piotr Rutkowski,Akmal Safwat,Patrick Schöffski,Stefan Sleijfer,Silvia Stacchiotti,Sandra J. Strauss,K. Sundby Hall,M. Unk,F. van Coevorden,W.T.A. van der Graaf,W.T.A. van der Graaf,W.T.A. van der Graaf,Jeremy Whelan,Eva Wardelmann,Olga Zaikova,Jean-Yves Blay +74 more
TL;DR: Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database, and different bone tumour subtypes have distinct patterns of incidence.
Journal ArticleDOI
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
S. Ferrari,K. Sundby Hall,Roberto Luksch,Amelia Tienghi,Thomas Wiebe,Franca Fagioli,Thor Alvegård,A. Brach del Prever,A. Tamburini,Marco Alberghini,Lorenza Gandola,Mario Mercuri,R. Capanna,S Mapelli,Arcangelo Prete,Modesto Carli,P. Picci,Enza Barbieri,G. Bacci,Sigbjørn Smeland +19 more
TL;DR: High-dose therapy added to the VACA-IE regimen in PR patients is feasible and effective and Selected groups of patients with ES can benefit from HDT.
Journal ArticleDOI
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
George D. Demetri,C. R. Antonescu,Bodil Bjerkehagen,Judith V.M.G. Bovée,Kjetil Boye,Matías Chacón,A. P. Dei Tos,Jayesh Desai,Jonathan A. Fletcher,Hans Gelderblom,Suzanne George,Alessandro Gronchi,Rick L. Haas,Nadia Hindi,Peter Hohenberger,Heikki Joensuu,Robin L. Jones,Ian Judson,Y-K. Kang,Akira Kawai,A. J. Lazar,A. Le Cesne,Roberta Maestro,Robert G. Maki,Javier Martin,Shreyaskumar Patel,Frédérique Penault-Llorca,C. Premanand Raut,Piotr Rutkowski,Akmal Safwat,Marta Sbaraglia,Inga-Marie Schaefer,Li Shen,César Serrano,Patrick Schöffski,Silvia Stacchiotti,K. Sundby Hall,William D. Tap,David Thomas,Jonathan C. Trent,Claudia Valverde,W.T.A. van der Graaf,W.T.A. van der Graaf,M. von Mehren,Anthony D. Wagner,Eva Wardelmann,Yoichi Naito,John Zalcberg,J.-Y. Blay +48 more
TL;DR: A diagnostic strategy is proposed that considers disease stage and histologic and molecular subtypes to facilitate routine testing for TRK expression and subsequent testing for NTRK gene fusions and is developed to provide practical guidance on the management of patients with sarcoma harboring N TRK genefusions.